165 related articles for article (PubMed ID: 1699786)
21. Selective alterations in natural killer cell subsets in patients with atopic dermatitis.
Wehrmann W; Reinhold U; Kukel S; Franke N; Uerlich M; Kreysel HW
Int Arch Allergy Appl Immunol; 1990; 92(3):318-22. PubMed ID: 1703517
[TBL] [Abstract][Full Text] [Related]
22. Selective homing of phenotypically lytic cells within nasopharyngeal carcinoma biopsies: numerous CD8- and CD16-positive cells in the tumor.
Lakhdar M; Ben Aribia MH; Maalej M; Ladgham A
Int J Cancer; 1991 Apr; 48(1):57-61. PubMed ID: 1826899
[TBL] [Abstract][Full Text] [Related]
23. CD3 negative "small agranular lymphocytes" are natural killer cells.
Inverardi L; Witson JC; Fuad SA; Winkler-Pickett RT; Ortaldo JR; Bach FH
J Immunol; 1991 Jun; 146(11):4048-52. PubMed ID: 1827820
[TBL] [Abstract][Full Text] [Related]
24. Activation of CD16+ effector cells by rheumatoid factor complex. Role of natural killer cells in rheumatoid arthritis.
Hendrich C; Kuipers JG; Kolanus W; Hammer M; Schmidt RE
Arthritis Rheum; 1991 Apr; 34(4):423-31. PubMed ID: 1707275
[TBL] [Abstract][Full Text] [Related]
25. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity.
Maïza H; Leca G; Mansur IG; Schiavon V; Boumsell L; Bensussan A
J Exp Med; 1993 Sep; 178(3):1121-6. PubMed ID: 7688788
[TBL] [Abstract][Full Text] [Related]
26. NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.
Keever CA; Pekle K; Gazzola MV; Collins NH; Gillio A
Cell Immunol; 1990 Mar; 126(1):211-26. PubMed ID: 1689220
[TBL] [Abstract][Full Text] [Related]
27. Age-associated changes in CD8+ and CD16+ cell reactivity: clonal analysis.
Mariani E; Roda P; Mariani AR; Vitale M; Degrassi A; Papa S; Facchini A
Clin Exp Immunol; 1990 Sep; 81(3):479-84. PubMed ID: 2144486
[TBL] [Abstract][Full Text] [Related]
28. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A
J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187
[TBL] [Abstract][Full Text] [Related]
29. CD16+ and CD56+ cells as markers of necrotizing and crescentic glomerulonephritis and active IgA glomerulonephropathy.
Hotta O; Seki S; Taguma Y; Shimoda A; Abo T; Takahashi H
Nephron; 1991; 57(2):239-40. PubMed ID: 1708443
[No Abstract] [Full Text] [Related]
30. Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells.
Leo R; Boeker M; Peest D; Hein R; Bartl R; Gessner JE; Selbach J; Wacker G; Deicher H
Ann Hematol; 1992 Mar; 64(3):132-9. PubMed ID: 1373957
[TBL] [Abstract][Full Text] [Related]
31. Functional and phenotypic assessment of neonatal human leucocytes expressing natural killer cell-associated antigens.
Bradstock KF; Luxford C; Grimsley PG
Immunol Cell Biol; 1993 Dec; 71 ( Pt 6)():535-42. PubMed ID: 7508887
[TBL] [Abstract][Full Text] [Related]
32. Identification of CD16/NKH-1+ natural killer cells and their relevance to cutaneous tumour immunity.
Markey AC; MacDonald DM
Br J Dermatol; 1989 Nov; 121(5):563-70. PubMed ID: 2480804
[TBL] [Abstract][Full Text] [Related]
33. Suppression of natural killer cell activity by rabbit antibody to human beta 2-microglobulin (beta 2m) is an Fc-mediated phenomenon and is not beta 2m specific.
Jones RA; Richards SJ; Patel D; Scott CS
Immunology; 1991 Jul; 73(3):342-7. PubMed ID: 1831793
[TBL] [Abstract][Full Text] [Related]
34. Activated lymphocyte subsets in adult periodontitis.
Afar B; Engel D; Clark EA
J Periodontal Res; 1992 Mar; 27(2):126-33. PubMed ID: 1372351
[TBL] [Abstract][Full Text] [Related]
35. Morphometric evaluation of CD16-positive cells with respect to CD2 antigen coexpression.
Manara GC; Ferrari C; Pagani L; Sansoni P; Bologna G; Molinari A; Torresani C; De Panfilis G
Cell Immunol; 1990 Jun; 128(1):118-29. PubMed ID: 1971527
[TBL] [Abstract][Full Text] [Related]
36. Psychosocial stress and NK cells among members of a communal settlement.
Schlesinger M; Yodfat Y; Rabinowitz R; Bronner S; Kark JD
Adv Exp Med Biol; 1993; 335():247-54. PubMed ID: 7694447
[TBL] [Abstract][Full Text] [Related]
37. In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors.
Mingari MC; Poggi A; Biassoni R; Bellomo R; Ciccone E; Pella N; Morelli L; Verdiani S; Moretta A; Moretta L
J Exp Med; 1991 Jul; 174(1):21-6. PubMed ID: 1711562
[TBL] [Abstract][Full Text] [Related]
38. Fc gamma RIII activation is different in CD16+ cytotoxic T lymphocytes and natural killer cells.
Uciechowski P; Gessner JE; Schindler R; Schmidt RE
Eur J Immunol; 1992 Jun; 22(6):1635-8. PubMed ID: 1376268
[TBL] [Abstract][Full Text] [Related]
39. Analysis of multidrug-resistance (MDR-1) glycoprotein and CD56 expression to separate monoclonal gammopathy from multiple myeloma.
Sonneveld P; Durie BG; Lokhorst HM; Frutiger Y; Schoester M; Vela EE
Br J Haematol; 1993 Jan; 83(1):63-7. PubMed ID: 7679588
[TBL] [Abstract][Full Text] [Related]
40. Rheumatoid arthritis serum or synovial fluid and interleukin 2 abnormally expand natural killer-like cells that are potent stimulators of IgM rheumatoid factor.
Santiago-Schwarz F; Kay C; Panagiotopoulos C; Carsons SE
J Rheumatol; 1992 Feb; 19(2):223-8. PubMed ID: 1378496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
